The mfluence of methyl-, hydroxy and ammo substituents on the electrochen-ucal behavlour of simple l,Cnaphthoand l,Cbenzoqumones, model compounds of many qumoid antitumour agents, m aqueous media was studied Sigmficant changes m electrochenncal behaviour were observed, potentially the result of a change m the electron density of the qumone moiety, pre-or post-protonation of substituents, hydrogen bond formation, tautomenzation reactions and stenc mteractions between the qumone moiety and substituents. The mformation obtained was of benefit m the elucidation of the reduction mechanisms of qumoid antitumour agents such as avndmylqumones and mitomycins Many well-known anticancer agents, such as the anthracyclines (doxorubicin), the rmtomycins (mitomycm C) and the aziridmylqumones (carboquone and trenimon), have a quinone function, whereas mitoxantrone, AZQ and BZQ are more recently developed quinoid agents, currently m phase I and II clinical trials (Fig. 1).
VP 16-213 in standard doses is active against a number of solid tumors. Its penetration into the cerebrospinal fluid (CSF) is very limited at these dose levels. In 10 patients treated with high-dose VP 16-213 (0.9-2.5 g/m2), CSF levels of up to 0.54 microgram/mL were detected. In two patients with central nervous system (CNS) metastases of small cell lung cancer (SCLC) a response was seen after 1.0 and 1.5 g/m2 intravenously. High-dose VP 16-213 can possibly play a role in the treatment of CNS metastases of SCLC. Its application in late intensification regimens as a form of prophylaxis of CNS metastases should be investigated.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.